ED vs VOR · P/E 18, rev $15.26B vs $813.9M cap
Consolidated Edison Inc (ED) versus Vor Biopharma Inc (VOR) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Vor Biopharma Inc (VOR) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
VOR does not have a complete income-statement cache yet.
ED currently screens at market cap $36.02B and trailing P/E 18.3. VOR currently screens at market cap $813.9M.
Not investment advice. Open the ED and VOR stock pages for the full models.
Not investment advice.